Jason Binder

Jason Binder is the founder and CEO of Ember, where he is building an AI companion to support patients and caregivers navigating serious illness, starting with glioblastoma.
He brings 25 years of experience across oncology drug development, clinical data, and enterprise transformation, with leadership roles at AstraZeneca, Genentech, and Merck & Co.. His work has focused on building clinical data and planning systems at enterprise scale—supporting portfolio decisions, capacity planning, and visibility across the drug development lifecycle.
That perspective changed when his wife was diagnosed with brain cancer. Sitting on the other side of the system he helped build, he experienced how difficult it is for patients and families to find, understand, and act on information when time is limited. That gap now shapes his work—focusing on patient-centered data, quality of life, and extending support beyond the clinic.
Jason writes and speaks on AI in healthcare, the role of lived experience in data, and new approaches to accelerating cancer innovation.